Galera Therapeutics, Inc. (GRTX) Financials
GRTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 37.8 million | 164.3 million |
2023-06-30 | 48.3 million | 163.3 million |
2023-03-31 | 59.7 million | 157.3 million |
2022-12-31 | 44.0 million | 153.2 million |
GRTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -12.5 million | 1.4 million |
2023-06-30 | -10.8 million | 1.5 million |
2023-03-31 | -11.7 million | 1.5 million |
2022-12-31 | -13.9 million | 1.7 million |
GRTX Net Income
No data available :(
GRTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 28.4 million | - | 1.3 million |
2023-06-30 | 38.8 million | - | 1.3 million |
2023-03-31 | 47.8 million | - | - |
2022-12-31 | 31.6 million | - | 44000 |
GRTX Shares Outstanding
GRTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 6.1 million | 5.0 million | - |
2023-06-30 | 50000 | 7.6 million | 9.2 million | - |
2023-03-31 | 50000 | 7.3 million | 6.6 million | - |
2022-12-31 | 50000 | 8.1 million | 5.0 million | - |
GRTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 12000 |
2023-06-30 | - | 12000 |
2023-03-31 | - | 20000 |
2022-12-31 | - | 26000 |
GRTX
Price: $0.19
52 week price:
Earnings Per Share: -1.88 USD
P/E Ratio: -0.09
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 52746
Market Capitalization: 9.0 million